Cover Image
市場調查報告書

MediPoint:電生理學檢驗 - 美國市場的分析與預測

MediPoint: Electrophysiology - US Analysis and Market Forecasts

出版商 GlobalData 商品編碼 297519
出版日期 內容資訊 英文 236 Pages
訂單完成後即時交付
價格
Back to Top
MediPoint:電生理學檢驗 - 美國市場的分析與預測 MediPoint: Electrophysiology - US Analysis and Market Forecasts
出版日期: 2014年03月12日 內容資訊: 英文 236 Pages
簡介

電生理學(EP)檢查裝置市場仍在初期階段,不過許多醫生累積診斷和切除技術的經驗,隨著購買補助設備的醫院數量也逐漸增加,而大幅成長。由於下一代切除技術的出現,及診斷導管的改良、檢驗系統的進步、模式改良使患者暴露輻射劑量降低,更加促進診斷器具的利用。

本報告提供美國的電生理學檢查裝置市場相關調查分析、產業概要、市場區隔分析、市場預測、競爭評估、開發中產品相關驗證,再加上主要企業簡介、交易分析等,為您概述為以下內容。

第1章 目錄

第2章 簡介

第3章 產業概要

  • 簡介
  • 解剖生理學
  • 臨床表現
  • 診斷
  • 流行病學
  • 市場區隔
  • 治療成本、價格設定、給付制度
  • 市場特徵
  • 法規的問題/回收

第4章 市場區隔分析

  • 切除治療用導管
  • 診斷導管
  • 實驗室系統

第5章 市場預測:各地區

  • 美國

第6章 策略性競爭評估

  • 主要企業的市場佔有率

第7章 現在/未來的主要企業

  • 概要、投資組合、SWOT分析等
    • Biosense Webster
    • Biotronik
    • Boston Scientific
    • CardioFocus
    • CardioInsight
    • Hansen Medical
    • Imricor
    • 日本life line
    • Magnetecs Corporation
    • Medtronic
    • MicroPort Scientific Company
    • St. Jude Medical
    • Stereotaxis
    • Stryker Sustainability Solutions
    • Topera Medical

第8章 開發中產品的評估

  • 各開發階段
  • 市場區隔分析
  • 實驗室系統

第9章 策略性交易分析

  • 主要的收購
  • 主要的夥伴關係

第10章 附錄

圖表

目錄
Product Code: GDME1088CFR

Still in its infancy, the electrophysiology (EP) device market has seen significant adoption; as more physicians become experienced in diagnostic and ablation techniques, increasing numbers of hospitals purchase supportive equipment, device price-points fall, and efficacy improves. This continued growth is also driven by technological advancements including the emergence of next-generation ablation technologies, improvements in catheter diagnostics, and advancements in lab systems. Further, as imaging modalities improve, patients are exposed to less radiation than ever before, which will only further drive diagnostics.

The EP market in the US continues to grow and is driven by new physician adoption, increases in patient awareness, improvements in reimbursement, and the introduction of next-generation devices. As players in the market further consolidate, as seen with Boston Scientific's acquisition of C.R. Bard, competition continues to rise with a select number of manufacturers fighting for valuable market share.

Scope

  • An overview of electrophysiology, which includes epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines.
  • Annualized US electrophysiology market revenue from 2005 to 2013, forecast for 7 years to 2020.
  • Investigation of current and future market competition for electrophysiology
  • Insightful review of the key industry drivers, restraints and challenges as well as predicted impact of key events.
  • Competitor assessment including device approval analysis and device sales forecasts.
  • Marketed and pipeline product profiles covering efficiency, safety, clinical study details, device approvals, product positioning and device sales forecast.
  • Analysis of unmet needs within the market and opportunities for future players.
  • Technology trends evaluation to assess strength of pipeline.
  • An overview of all devices in development including clinical study details, design and material selection considerations, efficacy reports, and device approval timelines.
  • Company profiles including business description, financial overview and SWOT analysis.
  • Coverage of key market players.
  • Strategic assessment of the electrophysiology sector through market impact analysis, future market scenario and company analysis.
  • Direct quotes from Key Opinion Leaders (KOL)

Reasons to buy

  • Understand the trends shaping and driving the US electrophysiology market.
  • Realize device preferences of physicians who have performed the tests already.
  • Access market sizing, forecasts and quantified growth opportunities in the US electrophysiology market through 2020.
  • Quantify candidate patient populations to better design product pricing & launch plans.
  • Drive revenues, formulate effective sales and marketing strategies and gain in-depth understanding of the competitive landscape.
  • Perform benchmarking analysis of growth opportunities against currently marketed products.
  • Assess competitiveness of products in market by understanding the strengths and weaknesses of current competition.
  • Take a comprehensive look at the market's device pipeline and identify promising, paradigm-shifting products.
  • Create an effective counter-strategy to gain a competitive advantage against those currently in the market.
  • Organize your sales and marketing efforts by identifying the market categories and segments that present the best opportunities for growth.
  • What's the next big thing in the US electrophysiology market landscape? Identify, understand and capitalize.

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. Catalyst
  • 2.2. Related Reports

3. Industry Overview

  • 3.1. Introduction
  • 3.2. Anatomy and Physiology
    • 3.2.1. Etiology
    • 3.2.2. Risk Factors
    • 3.2.3. Types of Arrhythmia
  • 3.3. Clinical Presentation
    • 3.3.1. Symptoms
  • 3.4. Diagnosis
    • 3.4.1. Blood and Urine Diagnostic Procedures
    • 3.4.2. Electrocardiography-Based Diagnostic Procedures
    • 3.4.3. Computerized Tomographic Angiography
    • 3.4.4. Electrophysiological Testing
    • 3.4.5. Electromechanical Wave Imaging
    • 3.4.6. Echocardiography
    • 3.4.7. Tilt-Taable Testing
    • 3.4.8. Diagnostic and Electrophysiological Studies
    • 3.4.9. New York Heart Association Scale
    • 3.4.10. American College of Cardiology Scale
  • 3.5. Epidemiology
    • 3.5.1. Prevalence
  • 3.6. Market Segmentation
    • 3.6.1. Electrophysiology Diagnostic Catheter
    • 3.6.2. Electrophysiology Ablation Catheter
    • 3.6.3. Electrophysiology Lab Systems
  • 3.7. Treatment Costs, Pricing, and Reimbursement
    • 3.7.1. Direct Costs
    • 3.7.2. Indirect Costs
    • 3.7.3. US Costs
    • 3.7.4. Pricing of Electrophysiology Devices and Equipment
    • 3.7.5. Reimbursement
  • 3.8. Market Characterization
    • 3.8.1. Growing Patient Population Suitable for Treatment
    • 3.8.2. Increasing Prevalence of Arrhythmia with Age
    • 3.8.3. Emergence of Remote Catheter Navigation and Ablation Technology
    • 3.8.4. Focus on the Development of "Single Shot" Devices
    • 3.8.5. Catheter Localization Aided by Novel Mapping and Visualization Techniques
    • 3.8.6. Electrophysiology Market Trends in Inorganic Growth through Consolidation
    • 3.8.7. Lack of Skilled and Experienced Electrophysiologists to Negatively Impact Procedure Volumes and Hinder Market Growth
    • 3.8.8. Awareness and Education to Drive Earlier Intervention
  • 3.9. Regulatory Issues and Recalls

4. Segment Analysis

  • 4.1. Ablation Catheters Market Dynamics
    • 4.1.1. Ablation Catheters Market Drivers
    • 4.1.2. Ablation Catheters Market Barriers
  • 4.2. Diagnostic Catheters Market Dynamics
    • 4.2.1. Diagnostic Catheters Market Drivers
    • 4.2.2. Diagnostic Catheters Market Barriers
  • 4.3. Lab Systems Market Dynamics
    • 4.3.1. Lab Systems Market Drivers
    • 4.3.2. Lab Systems Market Barriers

5. Market Outlooks by Geography

  • 5.1. US
    • 5.1.1. Overview
    • 5.1.2. Market Analysis

6. Strategic Competitive Assessment

  • 6.1. Key Company Share
    • 6.1.1. Overview
    • 6.1.2. US

7. Current and Future Players

  • 7.1. Biosense Webster
    • 7.1.1. Overview
    • 7.1.2. Portfolio Evaluation
    • 7.1.3. Biosense Webster SWOT Analysis
  • 7.2. Biotronik
    • 7.2.1. Overview
    • 7.2.2. Portfolio Evaluation
    • 7.2.3. Biotronik SWOT Analysis
  • 7.3. Boston Scientific
    • 7.3.1. Overview
    • 7.3.2. Boston Scientific Acquires Bard EP and Rhythmia Medical
    • 7.3.3. Portfolio Evaluation
    • 7.3.4. Boston Scientific SWOT Analysis
  • 7.4. CardioFocus
    • 7.4.1. Overview
    • 7.4.2. Portfolio Evaluation
    • 7.4.3. Company SWOT Analysis
  • 7.5. CardioInsight
    • 7.5.1. Overview
    • 7.5.2. Portfolio Evaluation
    • 7.5.3. CardioInsight SWOT Analysis
  • 7.6. Hansen Medical
    • 7.6.1. Overview
    • 7.6.2. Portfolio Evaluation
    • 7.6.3. Company SWOT Analysis
  • 7.7. Imricor
    • 7.7.1. Overview
    • 7.7.2. Portfolio Evaluation
    • 7.7.3. Company SWOT Analysis
  • 7.8. Japan Lifeline
    • 7.8.1. Overview
    • 7.8.2. Portfolio Evaluation
    • 7.8.3. Company SWOT Analysis
  • 7.9. Magnetecs Corporation
    • 7.9.1. Overview
    • 7.9.2. Portfolio Evaluation
    • 7.9.3. Company SWOT Analysis
  • 7.10. Medtronic
    • 7.10.1. Overview
    • 7.10.2. Portfolio Evaluation
    • 7.10.3. Company SWOT Analysis
  • 7.11. MicroPort Scientific Company
    • 7.11.1. Overview
    • 7.11.2. Portfolio Evaluation
    • 7.11.3. MicroPort Scientific SWOT Analysis
  • 7.12. St. Jude Medical
    • 7.12.1. Overview
    • 7.12.2. Portfolio Evaluation
    • 7.12.3. Company SWOT Analysis
  • 7.13. Stereotaxis
    • 7.13.1. Overview
    • 7.13.2. Portfolio Evaluation
    • 7.13.3. Commercial Positioning
    • 7.13.4. Company SWOT Analysis
  • 7.14. Stryker Sustainability Solutions
    • 7.14.1. Overview
    • 7.14.2. Portfolio Evaluation
    • 7.14.3. Company SWOT Analysis
  • 7.15. Topera Medical
    • 7.15.1. Overview
    • 7.15.2. Portfolio Evaluation
    • 7.15.3. Company SWOT Analysis

8. Pipeline Product Assessment

  • 8.1. Pipeline Assessment by Development Stage
  • 8.2. Segment Analysis of Pipeline Products
    • 8.2.1. Ablation Catheter Pipeline Products
    • 8.2.2. Diagnostic Catheter Pipeline Products
  • 8.3. Lab Systems
    • 8.3.1. Integrated X-Ray and Robotic Catheter System (Hansen Medical, Philips Healthcare)
    • 8.3.2. ClearTrace System (MRI Interventions)
    • 8.3.3. Robotic Catheter Guidance Lab System (North Carolina State University)
    • 8.3.4. Catheter Guidance Lab System (SCR)

9. Strategic Deals Analysis

  • 9.1. Key Acquisitions
    • 9.1.1. Boston Scientific Acquires C.R. Bard's Electrophysiology Business for $275m
    • 9.1.2. St. Jude Medical Acquires Endosense for $161m
    • 9.1.3. Boston Scientific Acquires Rhythmia Medical for $265m
  • 9.2. Key Partnerships
    • 9.2.1. Philips and Biosense Webster Technology Integration Agreement
    • 9.2.2. Biosense Webster Technology Integration Agreement with GE Healthcare Systems and Siemens Healthcare
    • 9.2.3. Abbott and St. Jude Medical Broaden Alliance in US Cardiovascular Device Market

10. Appendix

  • 10.1. Bibliography
  • 10.2. Abbreviations
  • 10.3. Report Methodology
    • 10.3.1. Overview
    • 10.3.2. Coverage
    • 10.3.3. Secondary Research
    • 10.3.4. Forecasting Methodology
    • 10.3.5. Primary Research - Key Opinion Leader Interviews
    • 10.3.6. Expert Panel Validation
  • 10.4. Physicians Included in this Study
  • 10.5. About the Authors
    • 10.5.1. Analysts
    • 10.5.2. Global Head of Healthcare
  • 10.6. About MediPoint
  • 10.7. About GlobalData
  • 10.8. Disclaimer

List of Tables

  • Table 1: New York Heart Association Scale
  • Table 2: American College of Cardiology Scale
  • Table 3: Prevalent Cases of Congestive Heart Failure, US, Ages ≥45 Years, Men and Women (N), 2012-2019
  • Table 4: Atrial Fibrillation Treatment Goals
  • Table 5: Reasons for Lack of Consensus on Site for Ablation
  • Table 6: Techniques for Treatment of Persistent and Permanent Atrial Fibrillation
  • Table 7: Types of Atrial Fibrillation based of Triggers
  • Table 8: Characteristics of Catheter Ablation by Arrhythmia Type (%)
  • Table 9: Rates of Occurrence of Major Complications with Catheter Ablation (%), 2003-2006
  • Table 10: Catheter Ablation Success for the Treatment of Atrial Fibrillation (%), Global, 1995-2002 & 2003-2006
  • Table 11: Catheter Ablation Success by Arrhythmia Type (%), 2009
  • Table 12: Classes of Recommendations
  • Table 13: Level of Evidence
  • Table 14: Estimation of Total Incremental Health Care Costs in Patients with Atrial Fibrillation ($), US, 2008
  • Table 15: Complications Associated with Atrial Fibrillation and Their Incremental Medicare Costs, US, 2008
  • Table 16: Average Selling Price of Electrophysiology Products by Type, US, 2013
  • Table 17: Percentage of Population Age 65 and Older, US, 2005-2015
  • Table 18: Overview of the Applications, Benefits, Limitations, and Future Directions of Remote Navigation Systems in Electrophysiology
  • Table 19: Key Acquisitions in the Electrophysiology Devices Market
  • Table 20: Advantages and Disadvantages of Various Energy Sources Used for Catheter Ablation
  • Table 21: Experimental Theories of How Atrial Fibrillation Perpetuates
  • Table 22: Antiarrhythmic Drug Classification by Mode of Action
  • Table 23: Major Complications Associated with Catheter Ablation
  • Table 24: Complications Associated with Catheter Ablation
  • Table 25: Recently Approved and Investigational Antiarrhythmic Drugs Under Development
  • Table 26: Diagnosed Patient Volume by Disease Type, Diagnosed Patients (N), US, 2013
  • Table 27: Ablation Catheters Market, US, Historic Revenue ($m), 2005-2013
  • Table 28: Ablation Catheters Market, US, Forecast Revenue ($m), 2013-2020
  • Table 29: Diagnostic Catheters Market, US, Historic Revenue ($m), 2005-2013
  • Table 30: Diagnostic Catheters Market, US, Forecast Revenue ($m), 2013-2020
  • Table 31: Lab Systems Market, US, Historic Revenue ($m), 2005-2013
  • Table 32: Lab Systems Market, US, Forecast Revenue ($m), 2013-2020
  • Table 33: Company Share, US, Total Electrophysiology Market Revenue (%), 2012
  • Table 34: Company Profile - Biosense Webster
  • Table 35: Biosense Webster, Electrophysiology Devices Portfolio
  • Table 36: SWOT Analysis - Biosense Webster
  • Table 37: Company Profile - Biotronik
  • Table 38: Biotronik, Electrophysiology Devices Portfolio
  • Table 39: SWOT Analysis - Biotronik
  • Table 40: Company Profile - Boston Scientific
  • Table 41: Boston Scientific, Electrophysiology Devices Portfolio
  • Table 42: SWOT Analysis - Boston Scientific
  • Table 43: Company Profile - CardioFocus
  • Table 44: CardioFocus, Electrophysiology Devices Portfolio
  • Table 45: SWOT Analysis - CardioFocus
  • Table 46: Company Profile - CardioInsight
  • Table 47: CardioInsight, Electrophysiology Devices Portfolio
  • Table 48: SWOT Analysis - CardioInsight
  • Table 49: Company Profile - Hansen Medical
  • Table 50: Hansen Medical, Electrophysiology Devices Portfolio
  • Table 51: SWOT Analysis - Hansen Medical
  • Table 52: Company Profile - Imricor
  • Table 53: SWOT Analysis - Imricor
  • Table 54: Company Profile - Japan Lifeline
  • Table 55: Japan Lifeline, Electrophysiology Devices Portfolio
  • Table 56: SWOT Analysis - Japan Lifeline
  • Table 57: Company Profile - Magnetecs Corporation
  • Table 58: Magnetecs Corporation, Electrophysiology Devices Portfolio
  • Table 59: SWOT Analysis - Magnetecs Corporation
  • Table 60: Company Profile - Medtronic
  • Table 61: Medtronic, Electrophysiology Devices Portfolio, 2013
  • Table 62: SWOT Analysis - Medtronic
  • Table 63: Company Profile - MicroPort Scientific Company
  • Table 64: MicroPort Scientific, Electrophysiology Devices Portfolio
  • Table 65: SWOT Analysis - MicroPort Scientific
  • Table 66: Company Profile - St. Jude Medical
  • Table 67: St. Jude Medical, Electrophysiology Devices Portfolio
  • Table 68: SWOT Analysis - St. Jude Medical
  • Table 69: Company Profile - Stereotaxis
  • Table 70: Stereotaxis, Electrophysiology Devices Portfolio
  • Table 71: SWOT Analysis - Stereotaxis
  • Table 72: Company Profile - Stryker Sustainability Solutions
  • Table 73: Stryker Sustainability Solutions, Electrophysiology Devices Portfolio
  • Table 74: SWOT Analysis - Stryker Sustainability Solutions
  • Table 75: Company Profile - Topera Medical
  • Table 76: Topera Medical, Electrophysiology Devices Portfolio, 2013
  • Table 77: SWOT Analysis - Topera Medical
  • Table 78: Ablation Catheter Pipeline Products
  • Table 79: Diagnostic Catheter Pipeline Products
  • Table 80: Lab Systems Pipeline Products
  • Table 81: Catheter Ablation Device, Product Status
  • Table 82: Ablation Catheter Device - Transcutaneous Monitoring to Avoid Hypercapnea during Complex Catheter Ablations
  • Table 83: Apama Medical Ablation Catheter, Product Status
  • Table 84: Cooled Tip Catheter, Product Status
  • Table 85: MaPP-CS, Product Status
  • Table 86: ROF-AC, Product Status
  • Table 87: ROF-AS, Product Status
  • Table 88: Vision MR Ablation Catheter, Product Status
  • Table 89: Voyager Irrigated RFA Catheter, Product Status
  • Table 90: Navigation and Ablation Catheter, Product Status
  • Table 91: Hot Balloon Catheter, Product Status
  • Table 92: Lesion Assessment Device, Product Status
  • Table 93: Horizon MR Recording System, Product Status
  • Table 94: Integrated X-Ray and Robotic Catheter System, Product Status
  • Table 95: ClearTrace System, Product Status
  • Table 96: Robotic Catheter Guidance Lab System, Product Status
  • Table 97: Catheter Guidance Lab System, Product Status
  • Table 98: Key Acquisitions in the Electrophysiology Market

List of Figures

  • Figure 1: Types of Arrhythmia
  • Figure 2: Pulmonary Vein Ablation Procedure
  • Figure 3: Antiarrhythmic Drugs and/or Ablation for Rhythm Control in Atrial Fibrillation
  • Figure 4: Cost Comparison of Ablation versus Antiarrhythmic Drug Therapy, 2009
  • Figure 5: Breakdown of National Incremental Costs in patients with Atrial Fibrillation
  • Figure 6: Diagnosed Patient Volume by Disease Type, Diagnosed Patients (%), US, 2013
  • Figure 7: Ablation Catheters Market, US, Historic Revenue ($m), 2005-2013
  • Figure 8: Ablation Catheters Market, US, Forecast Revenue ($m), 2013-2020
  • Figure 9: Diagnostic Catheters Market, US, Historic Revenue ($m), 2005-2013
  • Figure 10: Diagnostic Catheters Market, US, Forecast Revenue ($m), 2013-2020
  • Figure 11: Lab Systems Market, US, Historic Revenue ($m), 2005-2013
  • Figure 12: Lab Systems Market, US, Forecast Revenue ($m), 2013-2020
  • Figure 13: Company Share, US, Total Electrophysiology Market Revenue (%), 2012
Back to Top